Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

E-cadherin promoter polymorphism (C-160A) and risk of recurrence in patients with superficial bladder cancer.

Clinical genetics - 1 Sept 2006

Lin J, Dinney C P, Grossman H B, Jhamb M, Zhu Y, Spitz M R, Wu X

Abstract excerpt

Tumor recurrence is a hallmark of superficial bladder cancer. Currently, a molecular marker for bladder cancer recurrence is lacking. E-cadherin plays an important role in epithelial development and in the establishment and maintenance of cell-cell adhesion and tissue architecture. The purpose of this study is to investigate the association of an E-cadherin promoter polymorphism (CDH1c-160a) with the risk of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cadherins
Share to Gene Frequency
Share to Genetic Markers

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Neoplasm Recurrence, Local

Share to Polymorphism, Single Nucleotide

Share to Promoter Regions, Genetic

Share to Urinary Bladder Neoplasms

Source

Identifiers

PMID: 16922727
DOI: 10.1111/j.1399-0004.2006.00666.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

E-cadherin promoter polymorphism (C-160A) and risk of recurrence in patients with superficial bladder cancer.PMID 16922727Read ↗

Nucleotide excision repair gene polymorphisms and recurrence after treatment for superficial bladder cancer.Semantic proximity Read ↗

Interplay between CDH1 polymorphisms, haplotypes, and genomic repetitive elements in urothelial bladder cancer prognosis.Semantic proximity Read ↗

The pharmacogenetic impact of inflammatory genes on bladder cancer recurrence.Semantic proximity Read ↗

Molecular Determinants of Tumor Recurrence in The Urinary BladderSemantic proximity Read ↗

Contribution of the -160C/A polymorphism in the E-cadherin promoter to cancer risk: a meta-analysis of 47 case-control studies.Semantic proximity Read ↗

Association between a C/A single nucleotide polymorphism of the E-cadherin gene promoter and transitional cell carcinoma of the bladder.Semantic proximity Read ↗

The impact of single-nucleotide polymorphisms on intravesical recurrence after bacillus Calmette-Guérin therapy for non-muscle invasive bladder cancer in a genome-wide association study.Semantic proximity Read ↗

Loss of heterozygosity on chromosomes 11 and 17 are markers of recurrence in TCC of the bladder.Semantic proximity Read ↗

Single nucleotide polymorphisms and risk of recurrence of renal-cell carcinoma: a cohort study.Semantic proximity Read ↗

DNA polymorphisms in exon 1 and promoter of the CDH1 gene and relevant risk of transitional cell carcinoma of the urinary bladder.Semantic proximity Read ↗

Insertion/deletion polymorphism in the promoter of NFKB1 as a potential molecular marker for the risk of recurrence in superficial bladder cancer.Semantic proximity Read ↗

No association exists between E-cadherin gene polymorphism and tumor recurrence in patients with hepatocellular carcinoma after transplantation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.